Metabolomic identification of biochemical changes induced by fluoxetine in an insulinoma cell line (MIN6)

Surachai Ngamratanapaiboon1, Krittaboon Pornchokchai2, Siriphattarinya Wongpitoonmanachai2

  • 1Division of Pharmacology, Department of Basic Medical Sciences, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Dusit, Bangkok, 10300, Thailand.

PubMed
Abstract

Insights

Fluoxetine may impair pancreatic beta-cell function. This study used metabolomics to show fluoxetine perturbs the citric acid cycle in MIN6 cells, offering insights into its cellular effects.

Area of Science:

  • Cellular biology
  • Metabolomics
  • Pharmacology

Background:

  • Fluoxetine use is linked to pancreatic beta-cell dysfunction.
  • The precise mechanism of fluoxetine's action on beta cells remains unclear.

Purpose of the Study:

  • To investigate the cellular response of MIN6 cells to fluoxetine.
  • To elucidate the molecular mechanisms underlying fluoxetine's effects on beta cells using metabolomics.

Main Methods:

  • Untargeted cell-based metabolomics was employed.
  • MIN6 cells were treated with fluoxetine.
  • Metabolic profiling was conducted using liquid chromatography-high resolution mass spectrometry (LC-HRMS).
  • Data analysis involved principal component analysis and discriminant analyses.

Main Results:

  • Sixty-six differentially expressed metabolites were identified between control and fluoxetine-treated groups.
  • Fluoxetine treatment significantly perturbed the citric acid cycle in MIN6 cells.

Conclusions:

  • This study provides novel insights into the molecular mechanisms of fluoxetine's impact on pancreatic beta cells.
  • The findings highlight the perturbation of the citric acid cycle as a key cellular response to fluoxetine.

Related Concept Videos